Companies are investing heavily in complex injectables, respiratory therapies and biosimilars to improve margins and diversify portfolios. Kindly note that thi...
Indian pharmaceutical companies are strategically shifting focus beyond traditional US generics. They are now investing significantly in high-growth areas like complex injectables, respiratory therapies, and biosimilars. This diversification aims to improve profit margins and…
Market Samachar is a news aggregator. This article was originally published by rediff.com. Tap the button above to read the full story on their site.